Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial

PURPOSE: Phase 2 randomized trials suggest that stereotactic ablative radiation therapy improves progression-free and overall survival in patients with oligometastatic cancer, with phase 3 trials currently testing stereotactic ablative radiation therapy in up to 10 metastases. Whether stereotactic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Corkum, Mark T., Fakir, Hatim, Palma, David A., Nguyen, Timothy, Bauman, Glenn S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267486/
https://www.ncbi.nlm.nih.gov/pubmed/34278053
http://dx.doi.org/10.1016/j.adro.2021.100734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267486/
https://www.ncbi.nlm.nih.gov/pubmed/34278053
http://dx.doi.org/10.1016/j.adro.2021.100734

Ejemplares similares